ARGNF (ARGNF) Stock Price & Analysis

ARGNF (ARGNF) fell 3.81% to USD 803.19 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.

ARGNF last closed at USD 835; the session ranged USD 803.19–803.19 on volume of 1 shares. Market capitalization is $52.62B, with a 52-week range of USD 532.4–885 (PNK). Source: Nexqual, June 10, 2026 at 00:51 UTC.

Key Statistics (as of June 10, 2026 at 00:51 UTC)

PriceUSD 803.19
Change▼ 3.81% (down)
Previous CloseUSD 835
OpenUSD 803.19
Day RangeUSD 803.19 – 803.19
52-Week RangeUSD 532.4 – 885
Volume1 shares
Market Cap$52.62B
ExchangePNK

Technical Analysis (ARGNF)

Nexqual's technical model rates ARGNF "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.

Overall SignalBUY
RSI (14)79.98 (overbought)
vs SMA50Above (USD 780.69)
MACD21.52 (positive)

Analyst Ratings (ARGNF)

Wall Street analysts rate ARGNF "None", per Nexqual as of June 10, 2026 at 00:51 UTC.

Consensus RatingNone

Earnings (ARGNF)

Next Earnings Date2026-07-23
Revenue Estimate$1.23B

Source: Nexqual, June 10, 2026 at 00:51 UTC.

Financials & Fundamentals (ARGNF)

Total Revenue$4.74B
Revenue Growth (YoY)+62.60%
Gross Margin+58.11%
Operating Margin+30.01%
Profit Margin+31.40%
Debt / Equity0.64
Total Cash$4.44B
Total Debt$47.16M

Source: Nexqual, June 10, 2026 at 00:51 UTC.

Financial Health Score (ARGNF)

Nexqual rates ARGNF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:51 UTC.

GrowthStrong — Revenue +68% YoY (annual)
ProfitabilityStrong — Gross margin 58%, operating 30%
Balance SheetStrong — $4.44B cash vs $47M debt, net cash position
Cash FlowMixed — No data
EfficiencyMixed — No data

Ownership (ARGNF)

Insider Ownership+0.00%
Institutional Ownership+47.44%
Shares Outstanding62.19M
Float61.96M

Source: Nexqual, June 10, 2026 at 00:51 UTC.

Leadership (ARGNF)

ARGNF is led by Karen Massey (age 46), CEO & Executive Director, per Nexqual as of June 10, 2026 at 00:51 UTC.

CEO & Executive DirectorKaren Massey (age 46)
Co-Founder & Non-Executive Chairman of the BoardTimothy Van Hauwermeiren EMBA, M.Sc. (age 53)
Chief Financial OfficerKarl Gubitz (age 55)
Chief Scientific OfficerPeter Ulrichts (age 45)
Vice President of Corporate Development & StrategyArjen Lemmen M.Sc. (age 40)

Major Backers & Investors (ARGNF)

Notable institutional backers of ARGNF include EuroPacific Growth Fund-EUPAC Fund, Fidelity, Franklin Custodian Funds-FRANKLIN DYNATECH FUND, according to Nexqual as of June 10, 2026 at 00:51 UTC.

Active Investors

InvestorStake
EuroPacific Growth Fund-EUPAC Fund0.82%
Fidelity0.37%
Franklin Custodian Funds-FRANKLIN DYNATECH FUND0.32%
Prudential World Fd., Inc.-PGIM Jennison Intl Opportunities Fd.0.31%
Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund0.29%

Index Funds (Passive)

FundStake
Vanguard Group5.24%

Source: Nexqual, June 10, 2026 at 00:51 UTC.

Peers & Related Stocks

SymbolNamePriceChange
ALPMFAstellas Pharma, Inc.USD 14.26▲ 0.42%
BEIGFBEIGENE LTDUSD 23.75▲ 5.54%
SWZCFSWISSCOM AGUSD 860▲ 6.46%
DNBBYDNB ASAUSD 29.93▼ 0.07%
CLLNYCellnex Telecom SAUSD 16.36▲ 0.37%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.